ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
Koca, Emre, Niravath, Polly Ann, Ensor, Joe, Patel, Tejal Amar, Li, Xiaoxian, Hemati, Pej, Wong, Helen, Qian, Wei, Boone, Toniva, Zhao, Jing, Ramshesh, Priya V., Cohen, Adam Louis, Murthy, Asha, Nair, Sindhu, Darcourt, Jorge German, Belcheva, Anna, Kaklamani, Virginia G., Chang, Jenny Chee Ning
Published in Breast cancer research and treatment (01.07.2021)
Published in Breast cancer research and treatment (01.07.2021)
Get full text
Journal Article
Stereotactic body radiation therapy and in situ oncolytic virus therapy followed by immunotherapy in metastatic non-small cell lung cancer
Guerrero, Carlo, Ensor, Joe E., Sun, Kai, Farach, Andrew M., Nair, Sindhu, Zhang, Jun, Singh, Monisha, Darcourt, Jorge German, Ramshesh, Priya V., Butler, Edward Brian, Teh, Bin S., Sultenfuss, Mark, Gupta, Nakul, Heslop, Helen E., Mejia, Jaime A., Chang, Jenny Chee Ning, Bernicker, Eric
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Open label, phase II trial of neoadjuvant TAK-228 plus tamoxifen in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor type 2 (HER2)-negative breast cancer-ANETT
Koca, Emre, Niravath, Polly Ann, Ensor, Joe, Patel, Tejal Amar, Li, Xiaoxian, Hemati, Pej, Wong, Helen, Qian, Wei, Boone, Toniva, Zhao, Jing, Ramshesh, Priya V., Cohen, Adam Louis, Murthy, Asha, Nair, Sindhu, Darcourt, Jorge German, Belcheva, Anna, Kaklamani, Virginia G., Chang, Jenny Chee Ning
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article